REFERENCES
- Reinhart SC, Moses AM, Cleary L, et al. Acute interstitial nephritis with renal failure associated with propylthiouracil therapy. Am J Kidney Dis. Oct, 1994; 24(4)575–577
- Kudoh Y, Kuroda S, Shimamoto K, et al. Propylthiouracil-induced rapidly progressive glomerulonephritis associated with antineutrophil cytoplasmic autoantibodies. Clin Nephrol. Jul, 1997; 48(1)41–43
- Winters MJ, Hurley RM, Lirenman DS. ANCA-positive glomerulonephritis and IgA nephropathy in a patient on propylthiouracil. Pediatr Nephrol. Apr, 2002; 17(4)257–260
- Kitahara T, Hiromura K, Maezawa A, et al. Case of propylthiouracil-induced vasculitis associated with anti-neutrophil cytoplasmic antibody (ANCA); review of literature. Clin Nephrol. 1997; 47(5)336–340
- Dolman KM, Grans ROB, Vervaat TJ, et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet. 1993; 342: 651–652
- Booth AD, Pusey CD, Jayne DR. Renal vasculitis—an update in 2004. Nephrology Dialysis Transplantation. 2004; 19: 1964–1968
- Yuasa S, Hashimoto M, Yura T, et al. Antineutrophil cytoplasmic antibodies (ANCA)-associated crescentic glomerulonephritis and propylthiouracil therapy. Nephron. 1996; 73(4)701–703